Our toxicology group is dedicated to assisting clients develop appropriate study designs and select suitable biological models to investigate the safety of their compounds. We design and conduct standard preclinical studies to evaluate the safety of new drug candidates, as well as specialty studies with unique lab models to assess efficacy and ensure the quickest, most efficient route to investigational new drug (IND) submission. We have also specialized in developmental and reproductive toxicity (DART) studies for more than 25 years, establishing a reputation for conducting toxicology studies of the highest scientific caliber.
Nonclinical/Preclinical Toxicology
General toxicology capabilities
GLP-compliant studies
Compliance with FDA, ICH, EPA, and OECD guidelines
Range-finding, acute, subchronic, and chronic studies
